Gladstone NOW: The Campaign Join Us on the Journey ✕
31 - 45 of 1505 Results Clear All
Alzforum—Gladstone Investigator Lennart Mucke commented on new research that sheds light on how changes in brain activity and the immune system may contribute to synapse loss in Alzheimer’s disease.
Alzheimer’s Disease Mucke Lab Neurological Disease
New research shows low oxygen can help alleviate disease caused by defects in a mitochondrial quality control machinery.
News Release Research (Publication) Jain Lab Metabolism
Cerebral Valley—Gladstone partnered with Anthropic to host a virtual hackathon, bringing together researchers and developers to explore how AI can accelerate discovery. Explore the submissions, including the winner of the Gladstone Institutes Prize.
AI
National Postdoctoral Association—Gladstone is one of 12 recipients recognized for demonstrating outstanding commitment to advancing the postdoctoral experience.
Postdoctoral and Graduate Student Education and Research Development Affairs Postdoc Advisory Committee Institutional News
Gladstone is one of only 12 institutions nationwide to receive the award for its postdoctoral programs.
News Release Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Students and Postdocs Postdoc Advisory Committee Awards
Nearly 20 years after his landmark study uncovered novel roles of tau in Alzheimer’s disease, Gladstone's Lennart Mucke shares his perspective on new clinical data that could transform the future of brain health.
Mucke Lab Alzheimer’s Disease Gladstone Experts Neurological Disease News Release
The Circuit—Gladstone Investigator Jennifer Doudna discusses the origins of CRISPR and where it's headed, other breakthroughs in gene editing and what Silicon Valley gets wrong about the future of biology.
Doudna Lab CRISPR/Gene Editing AI
Kevin Pastores, assistant core director of Gladstone’s Flow Cytometry Core, helps researchers across disciplines design experiments, analyze complex cellular data, and harness emerging technologies like AI to accelerate discovery.
Profile Flow Cytometry Core
Scientific American recognizes Theodoris for her pioneering work developing artificial intelligence models to find treatments for an array of diseases.
East Bay Times—Gladstone Investigator Christina Theodoris developed an AI model that predicts how cells age and could accelerate the discovery of new treatments for age-related diseases.
Theodoris Lab
Scientific American—Gladstone Investigator Christina Theodoris is creating artificial-intelligence models to find treatments for cardiac diseases.
Theodoris Lab AI Cardiovascular Disease
The Gladstone scientist, an expert in vaccine development, is recognized for his pioneering approach to advancing human health and medicine.
Infectious Disease Awards
Los Angeles Times—Melanie Ott, director of the Gladstone Infectious Disease Institute, comments on emerging evidence that viral infections like COVID-19 may help reactivate dormant cancer cells, highlighting the need for more research into the links between viruses, inflammation, and cancer recurrence. (Subscription required.)
Ott Lab Infectious Disease COVID-19 Cancer
Peptides have become the latest cure-all trend on social media, but is the hype warranted? Deepak Srivastava warns that public enthusiasm may have surpassed the science.
Gladstone Experts
Gladstone scientists have developed a thinking microscope that can conduct its own experiments, with the ultimate goal of treating neurodegenerative diseases.
Finkbeiner Lab AI Center for Systems and Therapeutics Neurological Disease Alzheimer’s Disease Parkinson’s Disease ALS Huntington’s Disease
